Related references
Note: Only part of the references are listed.Bufalin induces apoptosis via mitochondrial ROS-mediated caspase-3 activation in HCT-116 and SW620 human colon cancer cells
Di Wu et al.
DRUG AND CHEMICAL TOXICOLOGY (2019)
Solid lipid nanoparticle induced apoptosis of macrophages via a mitochondrial-dependent pathway in vitro and in vivo
Wan-Li Liang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Mitochondria P-glycoprotein confers paclitaxel resistance on ovarian cancer cells
Weina Guo et al.
ONCOTARGETS AND THERAPY (2019)
Expression levels of MRP1, GST-π, and GSK3β in ovarian cancer and the relationship with drug resistance and prognosis of patients
Xiaojing Tong et al.
ONCOLOGY LETTERS (2019)
Emodin enhances antitumor effect of paclitaxel on human non-small-cell lung cancer cells in vitro and in vivo
Shuifang Chen et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Tetramethylpyrazine Enhances the Antitumor Effect of Paclitaxel by Inhibiting Angiogenesis and Inducing Apoptosis
Liang Zou et al.
FRONTIERS IN PHARMACOLOGY (2019)
Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression
Dan Liao et al.
MOLECULES (2019)
Tetrandrine-Induced Autophagy in MDA-MB-231 Triple-Negative Breast Cancer Cell through the Inhibition of PI3K/AKT/mTOR Signaling
Yubo Guo et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
Tetrandrine suppresses cervical cancer growth by inducing apoptosis in vitro and in vivo
Haiyan Zhang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis
Vu Hong Loan Nguyen et al.
JOURNAL OF OVARIAN RESEARCH (2019)
Tetrandrine inhibits deregulated cell cycle in pancreatic cancer cells: Differential regulation of p21(Cip1/Waf1), p27(Kip1) and cyclin D1
Karnika Singh et al.
CANCER LETTERS (2018)
Gallic acid sensitizes paclitaxel-resistant human ovarian carcinoma cells through an increase in reactive oxygen species and subsequent downregulation of ERK activation
Jessica Nayelli Sanchez-Carranza et al.
ONCOLOGY REPORTS (2018)
Tetrandrine suppresses adhesion, migration and invasion of human colon cancer SW620 cells via inhibition of nuclear factor-κB, matrix metalloproteinase-2 and matrix metalloproteinase-9 signaling pathways
Ta-Kuo Juan et al.
ONCOLOGY LETTERS (2018)
Tetrandrine suppresses lung cancer growth and induces apoptosis, potentially via the VEGF/HIF-1α/ICAM-1 signaling pathway
Zhuo Chen et al.
ONCOLOGY LETTERS (2018)
Dietary compound proanthocyanidins from Chinese bayberry (Myrica rubra Sieb. et Zucc.) leaves attenuate chemotherapy-resistant ovarian cancer stem cell traits via targeting the Wnt/β-catenin signaling pathway and inducing G1 cell cycle arrest
Yu Zhang et al.
FOOD & FUNCTION (2018)
Anticancer drug discovery from Chinese medicinal herbs
Mu-Yang Huang et al.
CHINESE MEDICINE (2018)
Effect of five novel 5-substituted tetrandrine derivatives on P-glycoprotein-mediated inhibition and transport in Caco-2 cells
Zhonglian Cao et al.
ONCOLOGY LETTERS (2018)
FAM46B inhibits cell proliferation and cell cycle progression in prostate cancer through ubiquitination of β-catenin
Tao Liang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Current status and future prospects of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) clinical trials in ovarian cancer
Renee A. Cowan et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2017)
Zhi Zhen Fang formula reverses Hedgehog pathway mediated multidrug resistance in colorectal cancer
Hua Sui et al.
ONCOLOGY REPORTS (2017)
Advanced Ovarian Cancer: Primary or Interval Debulking? Five Categories of Patients in View of the Results of Randomized Trials and Tumor Biology: Primary Debulking Surgery and Interval Debulking Surgery for Advanced Ovarian Cancer
Amin P. Makar et al.
ONCOLOGIST (2016)
Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy
Ting Liu et al.
ONCOTARGET (2016)
Myc and cell cycle control
Gabriel Bretones et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
Statement by the Kommission Ovar of the AGO: The New FIGO and WHO Classifications of Ovarian, Fallopian Tube and Primary Peritoneal Cancer
I. Meinhold-Heerlein et al.
GEBURTSHILFE UND FRAUENHEILKUNDE (2015)
FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication
Jaime Prat
JOURNAL OF GYNECOLOGIC ONCOLOGY (2015)
Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1
Tian Hu Wang et al.
ONCOLOGY REPORTS (2012)
Combination of Tetrandrine with cisplatin enhances cytotoxicity through growth suppression and apoptosis in ovarian cancer in vitro and in vivo
Yuxing Zhang et al.
CANCER LETTERS (2011)
Ovarian cancer: Age contrasts in incidence, histology, disease stage at diagnosis, and mortality
Rosemary Yancik
CANCER (2010)
Effect of tetrandrine combined with epirubicin on the growth of human breast carcinoma multidrug resistance cell line
Yue Hou et al.
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2008)
Lost in transcription: p21 repression, mechanisms, and consequences
AL Gartel et al.
CANCER RESEARCH (2005)
Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation
R. Z. Yusuf et al.
CURRENT CANCER DRUG TARGETS (2003)
Share Paper
